There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...

The Biden administration wants to expand access to popular weight loss drugs like Wegovy and Ozempic. The new proposal would ...

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

Millions of Americans would be eligible to have costly weight-loss drugs like Wegovy or Ozempic covered by Medicare or ...

Weight-loss drug makers are directly targeting employers in a campaign to expand health insurance coverage of their popular, ...

But their weight-loss properties grabbed the attention of the public and people without diabetes started seeking these drugs.

Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...

The diabetes drug, Ozempic, has been in the headlines, causing quite a stir. Senior writer for Drugwatch.com, Terry Turner, ...